Unknown

Dataset Information

0

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.


ABSTRACT: Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive targets for anticancer drug development. Herein, a set of anilino-1,4-naphthoquinone derivatives (3-18) was synthesized and investigated for their anticancer and EGFR inhibitory potentials. Among all tested compounds, three derivatives (3, 8, and 10) were selected for studying EGFR inhibitory activity (in vitro and in silico) due to their most potent cytotoxic activities against six tested cancer cell lines (i.e., HuCCA-1, HepG2, A549, MOLT-3, MDA-MB-231, and T47D; IC50 values = 1.75-27.91 μM), high selectivity index (>20), and good predicted drug-like properties. The experimental results showed that these three promising compounds are potent EGFR inhibitors with nanomolar IC50 values (3.96-18.64 nM). Interestingly, the most potent compound 3 bearing 4-methyl substituent on the phenyl ring displayed 4-fold higher potency than the known EGFR inhibitor, erlotinib. Molecular docking, molecular dynamics simulation, and MM/GBSA-based free energy calculation revealed that van der Waals force played a major role in the accommodations of compound 3 within the ATP-binding pocket of EGFR. Additionally, the 4-CH3 moiety of the compound was noted to be a key chemical feature contributing to the highly potent EGFR inhibitory activity via its formations of alkyl interactions with A743, K745, M766, and L788 residues as well as additional interactions with M766 and T790.

SUBMITTER: Mahalapbutr P 

PROVIDER: S-EPMC9161259 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.

Mahalapbutr Panupong P   Leechaisit Ronnakorn R   Thongnum Anusit A   Todsaporn Duangjai D   Prachayasittikul Veda V   Rungrotmongkol Thanyada T   Prachayasittikul Supaluk S   Ruchirawat Somsak S   Prachayasittikul Virapong V   Pingaew Ratchanok R  

ACS omega 20220518 21


Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive targets for anticancer drug development. Herein, a set of anilino-1,4-naphthoquinone derivatives (<b>3-18</b>) was synthesized and investigated for their anticancer and EGFR inhibitory potentials. Among all tested compounds, three derivatives (<b>3</b>, <b>8</b>, and <b>10</b>) were selected for studying EGFR inhibitory activity (<i>in vitro</i> and <i>in silico</i>) due to their most potent cytotoxic activities  ...[more]

Similar Datasets

| S-EPMC10500653 | biostudies-literature
| S-EPMC6466525 | biostudies-literature
| S-EPMC6925601 | biostudies-literature
| S-EPMC3423093 | biostudies-literature
| S-EPMC11418213 | biostudies-literature
| S-EPMC4304211 | biostudies-literature
| S-EPMC6071741 | biostudies-literature
| S-EPMC9230136 | biostudies-literature
| S-EPMC10141837 | biostudies-literature
| S-EPMC5800871 | biostudies-literature